MedTrace Logo

A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

NCT03596034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-06-14

No results posted yet for this study

Summary

A Study to Characterize Puff Topography with Use of a JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

Conditions

  • Tobacco Use
  • Nicotine Dependence, Other Tobacco Product
  • Tobacco Smoking

Interventions

OTHER

JUUL 5%, Virginia Tobacco, ENDS product

Subjects participate in a 15 day product use period during which subjects will be requested to predominantly use the JUUL 5% product ad libitum as their primary source of nicotine. Subjects will be asked to report their daily use of the JUUL 5% product and CPD throughout the 15 day product use period.

Sponsors & Collaborators

  • Rose Research Center, LLC

    collaborator INDUSTRY

  • Juul Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Jed Rose, MD · Rose Research Center, LLC

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-09
Primary Completion
2018-09-26
Completion
2018-09-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03596034 on ClinicalTrials.gov